Clinical Trials Browser

Advanced Malignant Solid Tumors × Injections × 90 days × Clear all

NCT07480733 2026-05-29

Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumors